LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Technologies (Paris:ERF) announces the launch of two RT-PCR assays to accurately diagnose respiratory diseases caused by SARS-CoV-2, Influenza ...
Please provide your email address to receive an email when new articles are posted on . The BD MAX Respiratory Viral Panel detected and differentiated between influenza A and B respiratory syncytial ...
MISSISSAUGA, Ontario, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces the expansion of its portfolio ...
In this webinar, our speakers will provide an introduction into the epidemiology of influenza A/B, RSV, COVID-19, Adenovirus, Human Metapneumovirus, Rhinovirus, Enterovirus, and Parainfluenza, ...
Last year, while experts were concerned about the “twindemic”, the flu season was virtually non-existent due to COVID-19 public health countermeasures. With COVID-19 vaccination rollouts and ...
In typical years, flu season begins to escalate in early autumn and proceeds through winter. In 2021, the pattern for respiratory illnesses appears unsettlingly different. “We’re seeing all these ...
BIRMINGHAM, Ala., Oct. 10, 2023 /PRNewswire/ -- Molecular Designs, a developer and manufacturer of molecular infectious disease assays, announces the release of its new Direct-PCR Covid/Flu/RSV ...
The Company intends to use the funds awarded by the National Institutes of Health for completion of its upper respiratory panel multiplex on Co-Dx PCR Home™ platform SALT LAKE CITY, July 13, 2023 ...
SALT LAKE CITY, Nov. 18, 2025 /PRNewswire/ --Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results